Clindacin Etz Swab
NDC Package 43538-172-60
Package Information
Clindacin Etz (clindamycin phosphate) swabs is a medication used to treat acne. This formulation utilizes a swab delivery system. Marketed by Eurofarma, Inc., this product is identified by NDC 43538-172 and is authorized under FDA application ANDA065049.
Identification & Billing
- RxCUI: 1091339 - Clindacin Pledget 1 % Medicated Pad
- RxCUI: 1091339 - clindamycin 10 MG/ML Medicated Pad [Clindacin]
- RxCUI: 1091339 - Clindacin 10 MG/ML Medicated Pad
- RxCUI: 1091339 - Clindacin ETZ (as clindamycin phosphate) 1 % Medicated Pad
- RxCUI: 1091339 - Clindacin P (as clindamycin phosphate) 1 % Medicated Pad
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 43538 - Eurofarma, Inc.
- 43538-172 - Clindacin Etz
- 43538-172-60 - 60 PACKET in 1 CARTON / 1 SWAB in 1 PACKET
- 43538-172 - Clindacin Etz
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (43538-172). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 43538-172-60 identifies a specific commercial package of 60 packet in 1 carton / 1 swab in 1 packet of Clindacin Etz, a human prescription drug labeled by Eurofarma, Inc.. This product is billed for "EA" each discreet unit and contains an estimated amount of 60 billable units per package. This swab is formulated for topical use and contains clindamycin phosphate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Eurofarma, Inc. on June 15, 2013. The current certification is valid through December 31, 2027.
What are the primary indications for this medication?
This medication is used to treat acne. It helps to decrease the number of acne lesions. Clindamycin is an antibiotic which works by stopping the growth of bacteria.
How is this Eurofarma, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 43538017260. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 60 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.